Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07532759
What this trial is testing

Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice

Who this might be right for
Obstructive JaundicePancreatic Head CancerPeriampullary Neoplasms+1 more
Xu'an Wang 100
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04308174
What this trial is testing

Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsGallbladder CancerCholangiocarcinoma
Asan Medical Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT07036380
What this trial is testing

MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma

Who this might be right for
Advanced Biliary Tract Carcinoma
Centre Hospitalier Universitaire de Besancon 75
Not applicableUnknownNCT06282120
What this trial is testing

Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01308840
What this trial is testing

Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer

Who this might be right for
Biliary Tract CancerGallbladder Cancer
University of Rochester 31
Not applicableNot Yet RecruitingNCT07556835
What this trial is testing

Outcomes After Liver and Biliary Resection at a High-Volume Center

Who this might be right for
Liver NeoplasmsHepatobiliary DiseasesCholangiocarcinoma+6 more
Azienda USL Toscana Centro 1,000
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableUnknownNCT03718897
What this trial is testing

Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing

Who this might be right for
Biliary Tract Cancer
Ji Kon Ryu 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06993025
What this trial is testing

Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

Who this might be right for
Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04172402
What this trial is testing

NGS as the First-line Treatment in Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
National Health Research Institutes, Taiwan 48
Not applicableUnknownNCT02809898
What this trial is testing

The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
RenJi Hospital 30
Not applicableUnknownNCT02752698
What this trial is testing

Domestic Surgical Robot Clinical Study

Who this might be right for
Gastric Ulcer With Perforation But Without ObstructionColon CancerCholecystolithiasis+5 more
The Third Xiangya Hospital of Central South University 200
Large-scale testing (Phase 3)WithdrawnNCT03579758
What this trial is testing

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Who this might be right for
Stage I Gallbladder Cancer AJCC v8Stage II Gallbladder Cancer AJCC v8Stage IIA Gallbladder Cancer AJCC v8+4 more
Emory University
Testing effectiveness (Phase 2)Looking for participantsNCT06620848
What this trial is testing

HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 49
Not applicableLooking for participantsNCT06246448
What this trial is testing

Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)

Who this might be right for
Gall Bladder Cancer
Karolinska University Hospital 94
Testing effectiveness (Phase 2)Ended earlyNCT00478140
What this trial is testing

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderMalignant Neoplasm+4 more
National Cancer Institute (NCI) 4
Not applicableActive Not RecruitingNCT07642791
What this trial is testing

Safety of Opportunistic Salpingectomy During Elective Laparoscopic Cholecystectomy.

Who this might be right for
Ovarian CancerCholecystolithiasis
University of Zurich 300
Testing effectiveness (Phase 2)WithdrawnNCT06017297
What this trial is testing

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

Who this might be right for
Borderline Resectable CarcinomaBiliary Tract Cancer
Georgetown University
Testing effectiveness (Phase 2)Looking for participantsNCT07733115
What this trial is testing

QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Shanghai Zhongshan Hospital 38
Next Page